Dextran-based redox-responsive doxorubicinprodrug micelles for overcoming multidrug resistance†
Abstract
Multidrug resistance (MDR) is one of the critical reasons for the failure of cancer chemotherapy. To overcome MDR, we have developed redox-responsive